New research conducted in mice offers insights into what’s going on at the molecular level that could cause people with diabetes to develop Alzheimer’s disease.
Updated: FDA’s safety review on CAR-Ts culminates in new boxed warnings of secondary cancer
The FDA has told Novartis, Gilead, Bristol Myers Squibb and Johnson & Johnson to add boxed warnings on the labels of six CAR-T therapies noting
January 24, 2024